Substituted methyl aryl or heteroaryl amide compounds

Details for Australian Patent Application No. 2005238291 (hide)

Owner Pfizer Inc.

Inventors Matsumoto, Yukari; Koike, Hiroki; KonI, Kana; Nakao, Kazunari; Okumura, Yoshiyuki; Yamagishi, Tatsuya

Agent Shelston IP

Pub. Number AU-A-2005238291

PCT Pub. Number WO2005/105732

Priority 60/568,088 04.05.04 US

Filing date 22 April 2005

Wipo publication date 10 November 2005

International Classifications

C07C 235/42 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07D 213/89 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105732 Priority application(s): WO2005/105732

14 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238292-Ortho substituted aryl or heteroaryl amide compounds

2005238287-7H-pyrrolo[2,3-d]pyrimidine derivatives, as well as their therapeutically acceptable salts, pharmaceutical preparations containing them and process for production the active agent